IDEAYA Biosciences, Inc.
IDYA
$25.00
$0.140.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.36% | 44.61% | -151.47% | 1.80% | -33.36% |
| Total Depreciation and Amortization | 8.83% | 76.21% | -36.46% | -7.75% | 1.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.07% | 41.37% | 18.61% | 24.50% | 154,800.00% |
| Change in Net Operating Assets | 8.58% | 23.19% | 251.30% | -114.50% | 395.04% |
| Cash from Operations | -3.53% | 50.40% | -147.10% | -49.73% | 24.95% |
| Capital Expenditure | 50.15% | -20.69% | -141.14% | 53.03% | 26.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.60% | 141.40% | -901.11% | -128.16% | 119.72% |
| Cash from Investing | -42.47% | 140.49% | -883.77% | -129.23% | 119.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.39% | 849.62% | -99.01% | 607.20% | -88.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -95.39% | 849.62% | -99.04% | 631.19% | -88.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.65% | 114.44% | -245.47% | 190.19% | 253.80% |